Hypocholesterolemic effects of plant sterols and stanols: Do the dose-response curves diverge?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 85, Issue 1, 2011, Pages 5-6

  Maki, Kevin C ^a   Rains, Tia M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; STANOZOLOL;

CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK REDUCTION;

ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERCHOLESTEROLEMIA; STEROLS;

EID: 79957736827     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.03.001     Document Type: Editorial

References (13)

1. Musa-Veloso K., Poon T.H., Elliot J.A., Chung C. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot. Essent. Fatty Acids 2011, Feb 21, (Epub ahead of print).
2. Talati R., Sobieraj D.M., Makanji S.S., Phung O.J., Coleman C.I. The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J. Am. Diet Assoc. 2010, 110:719-726.
3. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R. Stress workshop participants, efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 2003, 78(9):965-978.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report, Circulation 106 (2002) 3143-3421.
5. Food and Drug Administration: Food labeling: health claims; plant sterol/stanol esters and coronary heart disease; interim final rule. Fed. Reg.65 (2000) 54685-54739.
6. Demonty I., Ras R.T., van der Knaap H.C.M., Duchateau M.J.E., Meijer L., Zock P.L., Geleijnse J.M., Trautwein E.A. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J. Nutr. 2009, 139:271-284.
7. Scholle J.M., Baker W.L., Talati R., Coleman C.I. The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. J. Am. Coll. Nutr. 2009, 28:517-524.
8. Robinson J.G., Smith B., Maheshwari N., Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J. Am. Coll. Cardiol. 2005, 46:1855-1862.
9. Brown M.S., Goldstein J.L. Biomedicine. Lowering LDL-not only how low, but how long?. Science 2006, 311:1721-1723.
10. Cohen J.C., Boerwinkle E., Mosley T.H., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006, 354:1264-1272.
11. JBS, JBS 2: Joint British Societies guidelines on prevention of cardiovascular disease in clinical practice. British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association, Heart 91 (Suppl. 5) (2005) v1-v52.
12. Health Canada, Plant Sterols and Blood Cholesterol Lowering, Health Canada, Food Directorate, Health Products and Food Branch, Bureau of Nutritional Sciences, Ottawa (ON), 2010. Available at: 〈〉 (last accessed March 21, 2011). http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/assess-evalu/phytosterols-eng.php.
13. Jones P.J.H. Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterol. J. Clin. Lipidol. 2008, 2:S4-S10.